|
|||||
|
|
Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors |
|
| Authors: | K. Lewandowski M. Gniot M. Wojtaszewska Z. Kanduła R. Becht E. Paczkowska E. Mędraś E. Wasilewska M. Iwoła |
| Affiliation: | 1. Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland;2. Department of Hematology, Pomeranian Medical University, Szczecin, Poland;3. Department of Haematology Blood Neoplasms, and Bone Marrow Transplantation, Wroc?aw Medical University, Wroc?aw, Poland;4. Department of Hematology, Medical University of Bia?ystok, Bia?ystok, Poland |
| Abstract: | |
| Keywords: | chronic myeloid leukemia JAK2 and CALR gene mutations Philadelphia‐negative myeloproliferative neoplasm response criteria |